Jessica Sachs, Chief Medical Officer of Cogent Biosciences ($COGT), sold shares once on the open market in the last year, totaling $3.2 million. Her most recent sale occurred on December 26, 2025. With no purchases recorded, her sales rank 2,610th among 11,678 insiders, below the average of $8.6 million per seller and 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 26, 2025 | Cogent Biosciences, Inc. | $COGT | Sachs Jessica | Chief Medical Officer | S | Common Stock | 82642 | $38.70 | 133,938.0000 | 142,376,529 | 38.16% | 0.06% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Sachs Jessica | Chief Medical Officer | A | Common Stock | 50000 | $0.00 | 51,296.0000 | 142,376,529 | 3858.03% | 0.04% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Sachs Jessica | Chief Medical Officer | A | Common Stock | 320000 | $0.00 | 371,296.0000 | 142,376,529 | 623.83% | 0.22% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Sachs Jessica | Chief Medical Officer | F | Common Stock | 154716 | $39.45 | 216,580.0000 | 142,376,529 | 41.67% | 0.11% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Sachs Jessica | Chief Medical Officer | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 142,376,529 | 9999.99% | 0.05% |
| Jan. 23, 2025 | Cogent Biosciences, Inc. | $COGT | Sachs Jessica | Chief Medical Officer | A | Stock Option (Right to Buy) | 270000 | $0.00 | 270,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Cogent Biosciences, Inc. | $COGT | Sachs Jessica | Chief Medical Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |